Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00091559
Status:
COMPLETED
Last Update Posted:
2017-04-05
First Post:
2004-09-10
Brief Title:
Oral SAHA Suberoylanilide Hydroxamic Acid in Advanced Cutaneous T-cell Lymphoma 0683-001
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Mycosis Fungoides |
| Cutaneous T-cell Lymphoma |
| Sezary Syndrome |
Keywords:
| Name | View |
|---|---|
| CTCL | View |